Novavax

Novavax

Yahoo Finance • 5 days ago

Stocks making big moves this week: Bally's, Adobe, Novavax, Semtech, and STAAR Surgical

Stocks making big moves this week: Bally's, Adobe, Novavax, Semtech, and STAAR Surgical Check out the companies making headlines this week: Bally's (NYSE:BALY): Gaming, betting and entertainment company Bally's Corporation (NYSE:BALY) ro... Full story

Yahoo Finance • 5 days ago

HHS seeking public input on vaccine recommendation categories

[US Department of Health and Human Services] * HHS has issued a formal Request for Information that seeks public input on the categories used in federal vaccine recommendations and how shared decision-making between patients and doctors... Full story

Yahoo Finance • 7 days ago

Moderna shares double as cancer vaccine data rekindles investor hopes

By Christy Santhosh and Shashwat Chauhan Aug 19 (Reuters) - Moderna shares more than doubled on Wednesday, adding about $30 billion to its market value, after promising late-stage data on its personalized mRNA cancer ‌therapy developed wi... Full story

Yahoo Finance • 14 days ago

U.K. regulator reaffirms safety of childhood vaccination

[Syringe drawing liquid medication from medical vial] zhikun sun/iStock via Getty Images Days after President Donald Trump ordered major changes to the U.S. childhood immunization schedule, the U.K. drug regulator on Wednesday reaffirmed... Full story

Yahoo Finance • 21 days ago

Novavax (NVDA) Could Be 44% Undervalued Following Its Licensing Pivot And Cyclospora Focus

Get insights on thousands of stocks from the global community of over 7 million individual investors at Simply Wall St. Why Novavax's Licensing Pivot and Cyclospora Focus Matter Now Novavax (NVAX) is in the spotlight after shifting away... Full story

Yahoo Finance • 29 days ago

Novavax (NVAX) Stock Falls Amid Market Uptick: What Investors Need to Know

Novavax (NVAX) closed at $7.37 in the latest trading session, marking a -1.6% move from the prior day. This move lagged the S&P 500's daily gain of 0.21%. Meanwhile, the Dow experienced a rise of 1.03%, and the technology-dominated Nasdaq... Full story

Yahoo Finance • last month

NVO Stock Up on EC Approval of Wegovy Pill to Treat Obesity

Novo Nordisk NVO received a boost after the European Commission (EC) approved once-daily oral version of Wegovy (semaglutide 25 mg) for the treatment of adults with obesity, with at least one weight-related comorbidity, alongside a reduced... Full story

Yahoo Finance • last month

Spotting Winners: Gilead Sciences (NASDAQ:GILD) And Therapeutics Stocks In Q1

Spotting Winners: Gilead Sciences (NASDAQ:GILD) And Therapeutics Stocks In Q1 Quarterly earnings results are a good time to check in on a company's progress, especially compared to its peers in the same sector. Today we are looking at Gil... Full story

Yahoo Finance • 2 months ago

WHO begins experimental Ebola trial as Congo outbreak claims 500+ lives

Patients infected with the Bundibugyo strain of Ebola have begun receiving experimental treatments in a World Health Organization-sponsored clinical trial aimed at improving care for the rare viral disease, which has claimed more than 500... Full story

Yahoo Finance • 2 months ago

Novavax (NVAX) Stock Moves 1.36%: What You Should Know

In the latest trading session, Novavax (NVAX) closed at $9.59, marking a +1.36% move from the previous day. Meanwhile, the Dow gained 1.14%, and the Nasdaq, a tech-heavy index, lost 0.8%. Coming into today, shares of the vaccine maker had... Full story

Yahoo Finance • 2 months ago

1 Healthcare Stock with Impressive Fundamentals and 2 We Turn Down

1 Healthcare Stock with Impressive Fundamentals and 2 We Turn Down Personal health and wellness is one of the many secular tailwinds for healthcare companies. Shareholders who bet on the industry have been rewarded lately as healthcare st... Full story

Yahoo Finance • 3 months ago

Novavax set for a seventh straight decline

Shares of Novavax (NVAX [https://seekingalpha.com/symbol/NVAX]) fell 2.84% to $8.38 in the afternoon trade on Tuesday, adding to a six-session slide. The stock has fallen around 18% between June 1 and June 8, compared to a 2.56% decline i... Full story

Yahoo Finance • 3 months ago

3 Reasons NVAX is Risky and 1 Stock to Buy Instead

Novavax has had an impressive run over the past six months as its shares have beaten the S&P 500 by 27.6%. The stock now trades at $9.21, marking a 37.6% gain. This was partly due to its solid quarterly results, and the run-up might have i... Full story

Yahoo Finance • 3 months ago

GoodRx, RadNet, Addus HomeCare, Novavax, and Mettler-Toledo Shares Plummet, What You Need To Know

What Happened? A number of stocks fell in the afternoon session after the April PPI report showed wholesale inflation accelerating to 6% annually, with service-sector prices rising at their fastest pace in four years. Healthcare companie... Full story

Yahoo Finance • 3 months ago

The Top 5 Analyst Questions From Novavax’s Q1 Earnings Call

Novavax delivered first quarter results that surpassed Wall Street’s revenue and earnings estimates, leading to a significant positive market reaction. Management attributed the quarter’s performance to strong partner-driven revenue stream... Full story

Yahoo Finance • 3 months ago

3 Reasons Not to Buy Into the Hantavirus-Related Biotech Rally

An outbreak of the hantavirus on a cruise ship recently sparked a bit of a rally in the pharmaceutical and biotech industries. While no one hopes this will become a global health crisis, if it does, those companies that develop and market... Full story

Yahoo Finance • 4 months ago

Memory chip stocks hit record highs, pharma reacts to hantavirus concerns

Market Catalysts Host Julie Hyman and Yahoo Finance Senior Reporter Brooke DiPalma track several of the day's top trending stock tickers, including memory chip stocks Micron Technology (MU), Intel (INTC), and Qualcomm (QCOM) opening at rec... Full story

Yahoo Finance • 4 months ago

Moderna Stock Is Up 6% Today: Is It Outperforming Other Vaccine Stocks Like Pfizer and Novavax?

Quick Read Moderna (MRNA) stock surged on renewed Hantavirus vaccine interest following a cruise ship outbreak, with Q1 revenue beating consensus at $389M versus $236M expected, driven by $311M in international product sales. Pfizer (PFE)... Full story

Yahoo Finance • 4 months ago

Q4 Earnings Highlights: Regeneron (NASDAQ:REGN) Vs The Rest Of The Biotechnology Stocks

Quarterly earnings results are a good time to check in on a company’s progress, especially compared to its peers in the same sector. Today we are looking at Regeneron (NASDAQ:REGN) and the best and worst performers in the biotechnology ind... Full story

Yahoo Finance • 4 months ago

Spotting Winners: AbbVie (NYSE:ABBV) And Therapeutics Stocks In Q4

The end of the earnings season is always a good time to take a step back and see who shined (and who not so much). Let’s take a look at how therapeutics stocks fared in Q4, starting with AbbVie (NYSE:ABBV). Over the next few years, therap... Full story